{"id":"https://openalex.org/W4396599588","doi":"https://doi.org/10.1158/1538-7445.sabcs23-po2-05-05","title":"Abstract PO2-05-05: ELECTRA: An open-label, multicenter, phase 1b/2 study of elacestrant in combination with abemaciclib in patients with brain metastasis (mets) from estrogen receptor-positive (ER+), HER2-negative (HER2-) breast cancer (BC)","display_name":"Abstract PO2-05-05: ELECTRA: An open-label, multicenter, phase 1b/2 study of elacestrant in combination with abemaciclib in patients with brain metastasis (mets) from estrogen receptor-positive (ER+), HER2-negative (HER2-) breast cancer (BC)","publication_year":2024,"publication_date":"2024-05-02","ids":{"openalex":"https://openalex.org/W4396599588","doi":"https://doi.org/10.1158/1538-7445.sabcs23-po2-05-05"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs23-po2-05-05","doi":"https://doi.org/10.1158/1538-7445.sabcs23-po2-05-05","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs23-po2-05-05","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077026571","display_name":"Nuhad K. Ibrahim","orcid":"https://orcid.org/0000-0001-8660-243X","observed_orcids":["https://orcid.org/0000-0001-8660-243X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nuhad Ibrahim","raw_affiliation_strings":["1The University of Texas MD Anderson Cancer Center, Houston, Texas, United States;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of Texas MD Anderson Cancer Center, Houston, Texas, United States;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026459010","display_name":"Sung\u2010Bae Kim","orcid":"https://orcid.org/0000-0001-5588-8332","observed_orcids":["https://orcid.org/0000-0001-5588-8332"]},"institutions":[{"id":"https://openalex.org/I2801680663","display_name":"Asan Medical Center","ror":"https://ror.org/03s5q0090","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2801680663","https://openalex.org/I4210167194"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Sung-Bae Kim","raw_affiliation_strings":["2Asan Medical Center, Seoul, Republic of Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Asan Medical Center, Seoul, Republic of Korea;","institution_ids":["https://openalex.org/I2801680663"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022319770","display_name":"NU Lin","orcid":"https://orcid.org/0000-0003-2263-5413","observed_orcids":["https://orcid.org/0000-0003-2263-5413"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nancy Lin","raw_affiliation_strings":["3Dana-Farber Cancer Institute, and Harvard Medical School, Boston, Massachusetts, United States;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Dana-Farber Cancer Institute, and Harvard Medical School, Boston, Massachusetts, United States;","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010064853","display_name":"Ahmad Hussein Awada","orcid":"https://orcid.org/0000-0001-7412-9163","observed_orcids":["https://orcid.org/0000-0001-7412-9163"]},"institutions":[{"id":"https://openalex.org/I132053463","display_name":"Universit\u00e9 Libre de Bruxelles","ror":"https://ror.org/01r9htc13","country_code":"BE","type":"education","lineage":["https://openalex.org/I132053463"]},{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Ahmad Awada","raw_affiliation_strings":["4Institut Jules Bordet, Universit\u00e9 Libre de Bruxelles, Brussels, Belgium;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Institut Jules Bordet, Universit\u00e9 Libre de Bruxelles, Brussels, Belgium;","institution_ids":["https://openalex.org/I132053463","https://openalex.org/I2801838318"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076949146","display_name":"Eva Maria Ciruelos Gil","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101691","display_name":"Hospital Universitario 12 De Octubre","ror":"https://ror.org/00qyh5r35","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210101691","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Eva Ciruelos Gil","raw_affiliation_strings":["5Hospital Universitario 12 de octubre;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Hospital Universitario 12 de octubre;","institution_ids":["https://openalex.org/I4210101691"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Giulia Tonini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108499","display_name":"Menarini Group (Italy)","ror":"https://ror.org/02h1wg091","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210108499"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giulia Tonini","raw_affiliation_strings":["6Menarini Group;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Menarini Group;","institution_ids":["https://openalex.org/I4210108499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004289593","display_name":"Bartomeu Piz\u00e0 Vallespir","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108499","display_name":"Menarini Group (Italy)","ror":"https://ror.org/02h1wg091","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210108499"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Bartomeu Piza Vallespir","raw_affiliation_strings":["7Clinical Sciences, Menarini Ricerche S.p.A., Firenze, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Clinical Sciences, Menarini Ricerche S.p.A., Firenze, Italy;","institution_ids":["https://openalex.org/I4210108499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113532846","display_name":"Kathy Puvana Theall","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405265979","display_name":"Stemline Therapeutics (United States)","ror":"https://ror.org/034ms2s08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108499","https://openalex.org/I4405265979"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathy Puvana Theall","raw_affiliation_strings":["8Stemline Therapeutics;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Stemline Therapeutics;","institution_ids":["https://openalex.org/I4405265979"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003060935","display_name":"Erika Paige Hamilton","orcid":"https://orcid.org/0000-0002-1911-0336","observed_orcids":["https://orcid.org/0000-0002-1911-0336"]},"institutions":[{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erika Hamilton","raw_affiliation_strings":["9Sarah Cannon Research Institute (SCRI), Nashville, Tennessee, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9Sarah Cannon Research Institute (SCRI), Nashville, Tennessee, United States","institution_ids":["https://openalex.org/I4210100810"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":10,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"9_Supplement","first_page":"PO2","last_page":"05"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9595000147819519,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9595000147819519,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11600","display_name":"Brain Metastases and Treatment","score":0.03370000049471855,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/elacestrant","display_name":"elacestrant","score":0.9980000257492065},{"id":"https://openalex.org/keywords/abemaciclib","display_name":"abemaciclib","score":1.0},{"id":"https://openalex.org/keywords/brain-metastases","display_name":"brain metastases","score":0.8370000123977661},{"id":"https://openalex.org/keywords/estrogen-receptor-positive-breast-cancer","display_name":"estrogen receptor-positive breast cancer","score":0.9599999785423279},{"id":"https://openalex.org/keywords/her2-negative-breast-cancer","display_name":"HER2-negative breast cancer","score":0.9950000047683716},{"id":"https://openalex.org/keywords/selective-estrogen-receptor-degrader","display_name":"selective estrogen receptor degrader","score":0.9020000100135803},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.9919999837875366},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8050000071525574},{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.5720000267028809},{"id":"https://openalex.org/keywords/esr1-mutations","display_name":"ESR1 mutations","score":0.5879999995231628},{"id":"https://openalex.org/keywords/emerald-trial","display_name":"EMERALD trial","score":0.6420000195503235},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6420000195503235},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.6209999918937683},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.5619999766349792}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7184206247329712},{"id":"https://openalex.org/C2778164965","wikidata":"https://www.wikidata.org/wiki/Q1620196","display_name":"Brain metastasis","level":4,"score":0.6552071571350098},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6366185545921326},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.5995891094207764},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4985930919647217},{"id":"https://openalex.org/C2777164284","wikidata":"https://www.wikidata.org/wiki/Q277954","display_name":"Estrogen","level":2,"score":0.4437456727027893},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3330736756324768},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.3288455009460449},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.24502360820770264}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs23-po2-05-05","doi":"https://doi.org/10.1158/1538-7445.sabcs23-po2-05-05","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs23-po2-05-05","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4393988092","https://openalex.org/W7162683890","https://openalex.org/W7201837283","https://openalex.org/W4399323814","https://openalex.org/W4402561258","https://openalex.org/W4411287765","https://openalex.org/W7129252518","https://openalex.org/W4322774064","https://openalex.org/W4411288372","https://openalex.org/W4396588023"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Currently,":[2],"there":[3],"are":[4,197,269],"no":[5,410,435],"approved":[6],"systemic":[7,153],"treatment":[8,349,447],"options":[9],"specifically":[10],"for":[11,222,456],"patients":[12,76,163,188,198,227,385,436,444,481,566],"with":[13,69,77,95,109,160,164,185,189,199,563,567],"ER+/HER2-":[14,26,165],"BC":[15,27,166],"who":[16],"have":[17,229,242,386,477],"brain":[18,23,143,168,190,207,215,235,568],"metastasis.":[19,208],"The":[20,60,263,331],"prevalence":[21],"of":[22,31,55,123,151,214,266,290,328,339,348,381,394,468,559,583],"metastases":[24,144,216],"from":[25,192,374,571],"is":[28,36,156,174,217,306,516,519],"approximately":[29],"14%":[30],"women":[32,119],"(Aversa,":[33],"2014).":[34],"Elacestrant":[35,91],"a":[37,45,96,133,527],"next-generation":[38],"oral":[39],"SERD":[40],"that":[41],"was":[42,92,417,496],"evaluated":[43,159,335],"in":[44,75,116,142,162,183,187,246,350,389,484,499,561,565],"pivotal":[46],"phase":[47,177,210,225,332,376,391,465,556],"3":[48,506],"trial,":[49],"EMERALD,":[50],"as":[51],"monotherapy":[52],"vs.":[53],"standard":[54],"care":[56],"(SOC)":[57],"endocrine":[58,73,87,111],"therapy.":[59],"EMERALD":[61],"trial":[62],"reported":[63],"significantly":[64],"prolonged":[65],"progression-free":[66],"survival":[67,300],"(PFS)":[68],"elacestrant":[70,124,155,182,358,401,422,560],"vs":[71],"SOC":[72],"therapy":[74,88,245],"ER+/HER2\u2212":[78,200],"ESR1":[79],"mutated":[80],"(ESR1-mut)":[81],"mBC":[82,204],"following":[83],"progression":[84],"on":[85,446],"prior":[86,244,259],"(Bidard,":[89],"2022).":[90],"well":[93],"tolerated":[94],"manageable":[97],"safety":[98,372,452],"profile.":[99],"Most":[100],"adverse":[101],"events,":[102],"including":[103,250],"nausea,":[104],"were":[105],"low-grade":[106],"and":[107,167,205,233,257,298,326,414,434,453,473,493],"consistent":[108],"other":[110],"therapies.":[112],"A":[113],"clinical":[114,293],"study":[115,180,558],"healthy":[117],"postmenopausal":[118],"demonstrated":[120],"the":[121,127,149,212,247,272,340,343,375,390,395,415,457,464,494,500,584],"ability":[122],"to":[125,138,270,352,525],"cross":[126],"blood-brain":[128],"barrier":[129],"(Conlan,":[130],"2020).":[131,147],"Abemaciclib,":[132],"CDK4/6i,":[134],"has":[135,431],"been":[136,387,432,478],"shown":[137],"achieve":[139],"therapeutic":[140],"concentrations":[141],"tissue":[145],"(Tolaney,":[146],"Given":[148],"lack":[150],"current":[152],"treatments,":[154],"now":[157],"being":[158],"abemaciclib":[161,186,363,406,427,512,564],"metastasis":[169,191,236,569],"(NCT05386108).":[170],"Methods:":[171],"ELECTRA":[172],"(NCT05386108)":[173],"an":[175],"open-label":[176],"1b/2,":[178],"multicenter":[179],"evaluating":[181],"combination":[184,341,416,495,562],"ER+,":[193],"HER2-":[194],"BC.":[195],"Eligibility":[196],"locally":[201],"advanced":[202],"or":[203,489],"measurable":[206,234],"For":[209,224],"1b,":[211],"presence":[213],"allowed":[218],"but":[219],"not":[220],"required":[221],"eligibility.":[223],"2,":[226,421,492],"must":[228,241],"\u2265":[230,251],"1":[231,252,472,488],"active":[232],"per":[237,308],"RECIST":[238,309],"v1.1.":[239],"Patients":[240],"received":[243],"metastatic":[248],"setting,":[249],"ET,":[253],"\u22642":[254],"chemotherapy":[255],"regimens,":[256],"0-2":[258],"CDK4/6i":[260],"(excluding":[261],"abemaciclib).":[262],"primary":[264,304],"objectives":[265,281,315],"Phase":[267,274,278,302,312],"1b":[268,279,333,377,392,466],"determine":[271,526],"recommended":[273],"2":[275,303,313,476],"dose":[276,398,440,470,474,486,490,502],"(RP2D).":[277],"secondary":[280,314],"include":[282,316],"safety,":[283],"PK,":[284,325],"objective":[285,305],"response":[286,291,318],"rate":[287,295,319],"(ORR),":[288],"duration":[289],"(DoR),":[292],"benefit":[294],"(CBR),":[296],"PFS,":[297,323],"overall":[299],"(OS).":[301],"ORR":[307],"version":[310],"1.1.":[311],"intracranial":[317],"(RR),":[320],"DoR,":[321],"CBR,":[322],"OS,":[324],"quality":[327],"life":[329],"(QoL).":[330],"portion":[334,393,467],"dose-limiting":[336],"toxicities":[337],"(DLTs)":[338],"during":[342],"first":[344],"cycle":[345,449],"(28":[346],"days)":[347],"up":[351],"three":[353],"6-patient":[354],"cohorts,":[355],"starting":[356],"at":[357,448],"300":[359,402],"mg":[360,365,403,408,424,429,509,514],"daily":[361],"plus":[362],"100":[364,407,428],"twice":[366],"daily.":[367],"Here":[368],"we":[369],"report":[370],"initial":[371],"results":[373],"portion.":[378],"Results:":[379],"As":[380],"June":[382],"2023,":[383],"15":[384],"enrolled":[388],"trial.":[396],"At":[397],"level":[399,420,441,471,475,487,491,505],"1,":[400,442],"QD":[404,425,510],"+":[405,426,511],"BID,":[409],"patient":[411],"experienced":[412,437,482],"DLTs,":[413],"feasible.":[418],"Dose":[419,504],"400":[423,508],"BID":[430],"completed,":[433],"DLTs.":[438],"In":[439,463],"4/7":[443],"remain":[445],"5.":[450],"Additional":[451],"PK":[454],"data":[455],"cohorts":[458],"will":[459],"be":[460],"provided.":[461],"Conclusion:":[462],"ELECTRA,":[469],"completed.":[479],"No":[480],"DLTs":[483],"either":[485],"considered":[497],"feasible":[498],"respective":[501],"levels.":[503],"(elacestrant":[507],"150":[513],"BID)":[515],"proceeding.":[517],"Recruitment":[518],"actively":[520],"ongoing,":[521],"enabling":[522],"oral-oral":[523],"combinations":[524],"RP2D.":[528],"Citation":[529],"Format:":[530],"Nuhad":[531],"Ibrahim,":[532],"Sung-Bae":[533],"Kim,":[534],"Nancy":[535],"Lin,":[536],"Ahmad":[537],"Awada,":[538],"Eva":[539],"Ciruelos":[540],"Gil,":[541],"Giulia":[542],"Tonini,":[543],"Bartomeu":[544],"Piza":[545],"Vallespir,":[546],"Kathy":[547],"Puvana":[548],"Theall,":[549],"Erika":[550],"Hamilton.":[551],"ELECTRA:":[552],"An":[553],"open-label,":[554],"multicenter,":[555],"1b/2":[557],"(mets)":[570],"estrogen":[572],"receptor-positive":[573],"(ER+),":[574],"HER2-negative":[575],"(HER2-)":[576],"breast":[577],"cancer":[578],"(BC)":[579],"[abstract].":[580],"In:":[581],"Proceedings":[582],"2023":[585,591],"San":[586,594],"Antonio":[587],"Breast":[588],"Cancer":[589,600],"Symposium;":[590],"Dec":[592],"5-9;":[593],"Antonio,":[595],"TX.":[596],"Philadelphia":[597],"(PA):":[598],"AACR;":[599],"Res":[601],"2024;84(9":[602],"Suppl):Abstract":[603],"nr":[604],"PO2-05-05.":[605]},"counts_by_year":[{"year":2025,"cited_by_count":3}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2024-05-03T00:00:00"}